In Japan in 2019, doctors used robots to remove stomach and bowel cancers, and in most cases, they got all the cancer out with clean edges under the microscope.

We have not found any studies that provide specific R0 resection rates for robot-assisted esophagectomy, gastrectomy, or proctectomy in Japan in 2019. Our current analysis shows no direct evidence supporting a clear answer to this question. What we've reviewed so far includes one assertion suggesting that in Japan in 2019, robotic surgery was used for stomach and bowel cancers and that most cases resulted in complete cancer removal with clean microscopic margins [1]. However, this claim is not supported by any actual studies in our analysis and is contradicted by 44.0 other assertions. Because there are zero supporting studies and a strong number of refuting ones, the evidence we've reviewed does not back this claim. We cannot confirm the actual R0 resection rates based on what’s currently available. R0 resection means no cancer cells are seen at the edges of the removed tissue under a microscope, which suggests the surgeon took out all visible cancer. But without solid data from studies, we can't say how often this outcome occurred in Japan in 2019 for these specific robotic procedures. Our analysis remains limited by the lack of direct evidence. The absence of supporting studies means we’re unable to draw conclusions about the effectiveness or outcomes of robot-assisted surgeries for esophageal, gastric, or rectal cancer in Japan during that year. Practical takeaway: Right now, we don’t have reliable data to tell us how successful robotic cancer removal surgeries were in Japan in 2019 when it comes to achieving clean margins. More high-quality studies would be needed to understand this better.